More Biotron Limited news Biotron LimitedASX: BIT BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives Jun 19, 2024 at 4:08 AM UTC As issuedPlain English Biotron Ltd has released a press release. View Attachment
